Literature DB >> 23698306

Permissive replication of homologous murine rotavirus in the mouse intestine is primarily regulated by VP4 and NSP1.

Ningguo Feng1, Linda L Yasukawa, Adrish Sen, Harry B Greenberg.   

Abstract

Homologous rotaviruses (RV) are, in general, more virulent and replicate more efficiently than heterologous RV in the intestine of the homologous host. The genetic basis for RV host range restriction is not fully understood and is likely to be multigenic. In previous studies, RV genes encoding VP3, VP4, VP7, nonstructural protein 1 (NSP1), and NSP4 have all been implicated in strain- and host species-specific infection. These studies used different RV strains, variable measurements of host range, and different animal hosts, and no clear consensus on the host range restriction determinants emerged. We used a murine model to demonstrate that enteric replication of murine RV EW is 1,000- to 10,000-fold greater than that of a simian rotavirus (RRV) in suckling mice. Intestinal replication of a series of EW × RRV reassortants was used to identify several RV genes that influenced RV replication in the intestine. The role of VP4 (encoded by gene 4) in enteric infection was strain specific. RRV VP4 reduced murine RV infectivity only slightly; however, a reassortant expressing VP4 from a bovine RV strain (UK) severely restricted intestinal replication in the suckling mice. The homologous murine EW NSP1 (encoded by gene 5) was necessary but not sufficient for promoting efficient enteric growth. Efficient enteric replication required a constellation of murine genes encoding VP3, NSP2, and NSP3 along with NSP1.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23698306      PMCID: PMC3719818          DOI: 10.1128/JVI.00619-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Rotavirus VP3 expressed in insect cells possesses guanylyltransferase activity.

Authors:  M Liu; N M Mattion; M K Estes
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

2.  Nondefective rotavirus mutants with an NSP1 gene which has a deletion of 500 nucleotides, including a cysteine-rich zinc finger motif-encoding region (nucleotides 156 to 248), or which has a nonsense codon at nucleotides 153-155.

Authors:  K Taniguchi; K Kojima; S Urasawa
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

3.  Comparison of the rotavirus nonstructural protein NSP1 (NS53) from different species by sequence analysis and northern blot hybridization.

Authors:  S J Dunn; T L Cross; H B Greenberg
Journal:  Virology       Date:  1994-08-15       Impact factor: 3.616

4.  Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections.

Authors:  M Ciarlet; M K Estes; C Barone; R F Ramig; M E Conner
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs.

Authors:  L A Ward; B I Rosen; L Yuan; L J Saif
Journal:  J Gen Virol       Date:  1996-07       Impact factor: 3.891

6.  Analyses of homologous rotavirus infection in the mouse model.

Authors:  J W Burns; A A Krishnaney; P T Vo; R V Rouse; L J Anderson; H B Greenberg
Journal:  Virology       Date:  1995-02-20       Impact factor: 3.616

7.  Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.

Authors:  N Feng; J W Burns; L Bracy; H B Greenberg
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Determinants of rotavirus host range restriction--a heterologous bovine NSP1 gene does not affect replication kinetics in the pig.

Authors:  J C Bridger; W Dhaliwal; M J Adamson; C R Howard
Journal:  Virology       Date:  1998-05-25       Impact factor: 3.616

9.  Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMU-18006) in newborn infants in Venezuela.

Authors:  J Flores; G Daoud; N Daoud; M Puig; M Martinez; I Perez-Schael; R Shaw; H B Greenberg; K Midthun; A Z Kapikian
Journal:  Pediatr Infect Dis J       Date:  1988-11       Impact factor: 2.129

10.  Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model.

Authors:  Y Hoshino; L J Saif; S Y Kang; M M Sereno; W K Chen; A Z Kapikian
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

View more
  24 in total

1.  Structural basis for 2'-5'-oligoadenylate binding and enzyme activity of a viral RNase L antagonist.

Authors:  Kristen M Ogden; Liya Hu; Babal K Jha; Banumathi Sankaran; Susan R Weiss; Robert H Silverman; John T Patton; B V Venkataram Prasad
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

2.  Predicted structure and domain organization of rotavirus capping enzyme and innate immune antagonist VP3.

Authors:  Kristen M Ogden; Matthew J Snyder; Allison F Dennis; John T Patton
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

Review 3.  The Rotavirus Interferon Antagonist NSP1: Many Targets, Many Questions.

Authors:  Michelle M Arnold
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

4.  Reverse Genetics System for a Human Group A Rotavirus.

Authors:  Takahiro Kawagishi; Jeffery A Nurdin; Misa Onishi; Ryotaro Nouda; Yuta Kanai; Takeshi Tajima; Hiroshi Ushijima; Takeshi Kobayashi
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

5.  Reverse Genetics Reveals a Role of Rotavirus VP3 Phosphodiesterase Activity in Inhibiting RNase L Signaling and Contributing to Intestinal Viral Replication In Vivo.

Authors:  Yanhua Song; Ningguo Feng; Liliana Sanchez-Tacuba; Linda L Yasukawa; Lili Ren; Robert H Silverman; Siyuan Ding; Harry B Greenberg
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

6.  Complete genome characterization of recent and ancient Belgian pig group A rotaviruses and assessment of their evolutionary relationship with human rotaviruses.

Authors:  Sebastiaan Theuns; Elisabeth Heylen; Mark Zeller; Inge D M Roukaerts; Lowiese M B Desmarets; Marc Van Ranst; Hans J Nauwynck; Jelle Matthijnssens
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

7.  Serial Passaging of the Human Rotavirus CDC-9 Strain in Cell Culture Leads to Attenuation: Characterization from In Vitro and In Vivo Studies.

Authors:  Theresa Kathrina Resch; Yuhuan Wang; Sungsil Moon; Baoming Jiang
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

8.  An Optimized Reverse Genetics System Suitable for Efficient Recovery of Simian, Human, and Murine-Like Rotaviruses.

Authors:  Liliana Sánchez-Tacuba; Ningguo Feng; Nathan J Meade; Kenneth H Mellits; Philippe H Jaïs; Linda L Yasukawa; Theresa K Resch; Baoming Jiang; Susana López; Siyuan Ding; Harry B Greenberg
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

9.  Rotavirus Degrades Multiple Interferon (IFN) Type Receptors To Inhibit IFN Signaling and Protects against Mortality from Endotoxin in Suckling Mice.

Authors:  Adrish Sen; Ayushi Sharma; Harry B Greenberg
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

10.  Rotavirus Reprograms Multiple Interferon Receptors and Restricts Their Intestinal Antiviral and Inflammatory Functions.

Authors:  Adrish Sen; Nima D Namsa; Ningguo Feng; Harry B Greenberg
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.